UK markets open in 1 hour 43 minutes
NIKKEI 225
27,595.39 -90.08 (-0.33%) HANG SENG
21,324.96 +26.26 (+0.12%) CRUDE OIL
77.36 +0.22 (+0.29%) GOLD FUTURES
1,890.20 +5.40 (+0.29%) DOW
34,156.69 +265.67 (+0.78%) BTC-GBP
19,267.49 +154.57 (+0.81%)
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 06:15PM GMT
| Previous close | 1,461.00 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 10,464,897 |
| Market cap | 60.831B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 13.63 |
| EPS (TTM) | 1.09 |
| Earnings date | 26 Apr 2023 |
| Forward dividend & yield | 0.61 (4.25%) |
| Ex-dividend date | 23 Feb 2023 |
| 1y target est | N/A |
- Fool.co.uk
2 shares to buy in February for healthy dividends
Charlie Carman examines a pair of healthcare shares he'll buy in February for passive income, thanks to their rock-solid dividend yields. The post 2 shares to buy in February for healthy dividends appeared first on The Motley Fool UK.
- PA Media: Money
GlaxoSmithKline tops new business gender equality index
The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, bonuses, and pay.
- Zacks
GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod
GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.
© 2023 Yahoo. All rights reserved.
